Skip to content
10-Q

Quarterly Report

VIVEVE MEDICAL, INC.

0001437749-22-012122

← back to feed
Filed
May 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 11, 2022 10.64M sh
Capex Q1 2022 · Mar 31, 2022 $49K
Capex Q1 2022 · Mar 31, 2021 $85K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$5.09M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$3.25M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $14.05M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $19.16M
Stockholders Equity Q1 2022 · Mar 31, 2022 $10.16M
Stockholders Equity Q1 2022 · Dec 31, 2021 $15.07M
Stockholders Equity Q1 2022 · Mar 31, 2021 $27.54M
Stockholders Equity Q1 2022 · Dec 31, 2020 $6.97M
Current Liabilities Q1 2022 · Mar 31, 2022 $10.26M
Current Liabilities Q1 2022 · Dec 31, 2021 $4.53M
Total Liabilities Q1 2022 · Mar 31, 2022 $10.53M
Total Liabilities Q1 2022 · Dec 31, 2021 $10.85M
Current Assets Q1 2022 · Mar 31, 2022 $17.5M
Current Assets Q1 2022 · Dec 31, 2021 $22.24M
Total Assets Q1 2022 · Mar 31, 2022 $20.68M
Total Assets Q1 2022 · Dec 31, 2021 $25.91M
Eps Basic Q1 2022 · Mar 31, 2022 −$0.67
Eps Basic Q1 2022 · Mar 31, 2021 −$0.80
Sga Expense Q1 2022 · Mar 31, 2022 $3.65M
Sga Expense Q1 2022 · Mar 31, 2021 $3.58M
Rd Expense Q1 2022 · Mar 31, 2022 $2.14M
Rd Expense Q1 2022 · Mar 31, 2021 $1.93M
Net Income Q1 2022 · Mar 31, 2022 −$5.89M
Net Income Q1 2022 · Mar 31, 2021 −$5.79M
Operating Income Q1 2022 · Mar 31, 2022 −$5.47M
Operating Income Q1 2022 · Mar 31, 2021 −$5.13M
Gross Profit Q1 2022 · Mar 31, 2022 $320K
Gross Profit Q1 2022 · Mar 31, 2021 $382K
Cost Of Revenue Q1 2022 · Mar 31, 2022 $1.32M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $1.07M
Revenue Q1 2022 · Mar 31, 2022 $1.64M
Revenue Q1 2022 · Mar 31, 2021 $1.45M